Published in Cancer Nurs on October 20, 2015
Psychosocial Information Requirements for Multimorbid Breast Cancer Patients in Breast Centres in North Rhine Westphalia. Geburtshilfe Frauenheilkd (2015) 0.75
Cancer statistics, 2014. CA Cancer J Clin (2014) 72.81
Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med (1998) 13.87
The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med (1995) 11.32
The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res (2004) 9.79
The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties. Soc Sci Med (1998) 8.67
Information needs and sources of information among cancer patients: a systematic review of research (1980-2003). Patient Educ Couns (2005) 4.86
Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol (2004) 4.03
The unmet supportive care needs of patients with cancer. Supportive Care Review Group. Cancer (2000) 3.47
Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol (2005) 2.87
Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. J Natl Cancer Inst (2012) 2.49
Evaluation of an instrument to assess the needs of patients with cancer. Supportive Care Review Group. Cancer (2000) 2.37
Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol (1999) 2.29
Quality of life among younger women with breast cancer. J Clin Oncol (2005) 2.19
Age-related differences in the quality of life of breast carcinoma patients after treatment. Cancer (1999) 2.06
Cancer survivorship: a new challenge in delivering quality cancer care. J Clin Oncol (2006) 1.99
Functional impact of breast cancer by age at diagnosis. J Clin Oncol (2004) 1.91
Information needs, sources of information, and decisional roles in women with breast cancer. Oncol Nurs Forum (1996) 1.75
Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol (2010) 1.67
Fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer. J Clin Oncol (2005) 1.58
Brief assessment of adult cancer patients' perceived needs: development and validation of the 34-item Supportive Care Needs Survey (SCNS-SF34). J Eval Clin Pract (2009) 1.55
Information and service needs for young adult cancer survivors. Support Care Cancer (2008) 1.51
Adjuvant therapies for very young women with early stage breast cancer. Breast (2011) 1.43
The development and evaluation of a measure to assess cancer survivors' unmet supportive care needs: the CaSUN (Cancer Survivors' Unmet Needs measure). Psychooncology (2007) 1.37
Communication, quality of life and age: results of a 5-year prospective study in breast cancer patients. Ann Oncol (2003) 1.29
Young women's experience of breast cancer: defining young and identifying concerns. Psychooncology (2000) 1.26
A systematic review of quality of life instruments in long-term breast cancer survivors. Health Qual Life Outcomes (2012) 1.23
Development and pilot testing of a nurse-led posttreatment support package for bowel cancer survivors. Cancer Nurs (2011) 1.19
Vitality, mental health, and satisfaction with information after breast cancer. Patient Educ Couns (2006) 1.13
Patients' supportive care needs and psychological distress in advanced breast cancer patients in Japan. Jpn J Clin Oncol (2010) 1.07
Psychosocial distress in young cancer survivors. Semin Oncol Nurs (2009) 1.07
'Nothing fit me': nationwide consultations with young women with breast cancer. Health Expect (2006) 1.04
The unfulfilled promise: a systematic review of interventions to reduce the unmet supportive care needs of cancer patients. Support Care Cancer (2011) 1.03
Use of complementary and alternative medicine in breast cancer patients and their experiences: a cross-sectional study. Eur J Cancer (2012) 1.01
Consultations between patients with breast cancer and surgeons: a pathway from patient-centered communication to reduced hopelessness. J Clin Oncol (2012) 0.99
Examining emotional outcomes among a multiethnic cohort of breast cancer survivors. Oncol Nurs Forum (2011) 0.99
Premature menopause in young breast cancer: effects on quality of life and treatment interventions. J Thorac Dis (2013) 0.95
Unmet needs of breast cancer patients relative to survival duration. Yonsei Med J (2012) 0.94
Post-treatment regret among young breast cancer survivors. Psychooncology (2011) 0.92
Clinicopathological features of young patients (<35 years of age) with breast cancer in a Japanese Breast Cancer Society supported study. Breast Cancer (2013) 0.91
A qualitative study of the information needs of premenopausal women with breast cancer in terms of contraception, sexuality, early menopause, and fertility. Int J Gynaecol Obstet (2010) 0.91
The cancer support person's unmet needs survey: psychometric properties. Cancer (2009) 0.91
Physicians' knowledge, attitude, and behavior regarding fertility issues for young breast cancer patients: a national survey for breast care specialists. Breast Cancer (2012) 0.89
Cancer and its treatment effect on young breast cancer survivors. Semin Oncol Nurs (2009) 0.88
A survey of breast cancer physicians regarding patient involvement in breast cancer treatment decisions. Breast (2012) 0.85
After cancer: the unmet supportive care needs of survivors and their partners. J Psychosoc Oncol (2007) 0.83
Major concerns and needs of breast cancer patients. Cancer Nurs (1999) 0.83
The role of appearance investment in the adjustment of women with breast cancer. Psychooncology (2010) 0.81
A qualitative study of decision-making by breast cancer patients about telling their children about their illness. Support Care Cancer (2009) 0.79
Anxiety, depression and defense mechanisms associated with treatment decisional preferences and quality of life in non-metastatic breast cancer: a 1-year prospective study. Psychooncology (2013) 0.79
Measles virus: cellular receptors, tropism and pathogenesis. J Gen Virol (2006) 2.04
S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance. J Biol Chem (2005) 1.96
Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer. Breast Cancer Res Treat (2002) 1.69
Genetic evidence linking SAP, the X-linked lymphoproliferative gene product, to Src-related kinase FynT in T(H)2 cytokine regulation. Immunity (2004) 1.63
Measles virus infects both polarized epithelial and immune cells by using distinctive receptor-binding sites on its hemagglutinin. J Virol (2008) 1.62
Long untranslated regions of the measles virus M and F genes control virus replication and cytopathogenicity. J Virol (2005) 1.61
Activation of PI3K/Akt signaling and hormone resistance in breast cancer. Breast Cancer (2006) 1.57
Molecular detection of lymph node metastases in breast cancer patients: results of a multicenter trial using the one-step nucleic acid amplification assay. Clin Cancer Res (2009) 1.52
A Japanese phase I study of continuous oral capecitabine in patients with malignant solid tumors. Int J Clin Oncol (2005) 1.42
A human lung carcinoma cell line supports efficient measles virus growth and syncytium formation via a SLAM- and CD46-independent mechanism. J Virol (2007) 1.39
Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer. Int J Cancer (2005) 1.39
Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry. J Clin Oncol (2002) 1.36
Measles virus circumvents the host interferon response by different actions of the C and V proteins. J Virol (2008) 1.32
Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer. Breast Cancer (2009) 1.30
Translational inhibition and increased interferon induction in cells infected with C protein-deficient measles virus. J Virol (2006) 1.28
Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2. Breast Cancer (2013) 1.26
Phase II study of preoperative sequential FEC and docetaxel predicts of pathological response and disease free survival. Breast Cancer Res Treat (2007) 1.25
Clinical significance of the 21-gene signature (Oncotype DX) in hormone receptor-positive early stage primary breast cancer in the Japanese population. Cancer (2010) 1.23
Prognostic and predictive value of epidermal growth factor receptor in recurrent breast cancer. Clin Cancer Res (2002) 1.20
Primary signet-ring cell carcinoma of the colon and rectum: report of eight cases and review of 154 Japanese cases. Hepatogastroenterology (2006) 1.20
Both RIG-I and MDA5 RNA helicases contribute to the induction of alpha/beta interferon in measles virus-infected human cells. J Virol (2010) 1.18
Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis. Cancer (2002) 1.18
Characteristics of qualitative studies in influential journals of general medicine: a critical review. Biosci Trends (2009) 1.17
The association between Akt activation and resistance to hormone therapy in metastatic breast cancer. Eur J Cancer (2006) 1.16
Clinical and pathological features of intracystic papillary carcinoma of the breast. Surg Today (2009) 1.16
The 3' enhancer CNS2 is a critical regulator of interleukin-4-mediated humoral immunity in follicular helper T cells. Immunity (2012) 1.14
Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance. Am J Physiol Endocrinol Metab (2002) 1.12
Efficient rescue of measles virus from cloned cDNA using SLAM-expressing Chinese hamster ovary cells. Virus Res (2005) 1.10
Characteristic profiles among students and junior doctors with specific career preferences. BMC Med Educ (2013) 1.10
Factors associated with intentions to adhere to colorectal cancer screening follow-up exams. BMC Public Health (2006) 1.10
Phyllodes tumor of the breast: correlation between MR findings and histologic grade. Radiology (2006) 1.08
Docetaxel followed by fluorouracil/epirubicin/cyclophosphamide as neoadjuvant chemotherapy for patients with primary breast cancer. Jpn J Clin Oncol (2011) 1.07
Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR. Hepatogastroenterology (2008) 1.07
Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group. Breast Cancer Res Treat (2009) 1.05
The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells. Breast Cancer Res (2010) 1.02
Prognostic value of the combination of epidermal growth factor receptor and c-erbB-2 in breast cancer. Surgery (2003) 1.02
Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes. Cancer Chemother Pharmacol (2008) 1.01
Non-mass-like enhancement on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images. Eur J Radiol (2009) 1.00
Impact of FOXA1 expression on the prognosis of patients with hormone receptor-positive breast cancer. Ann Surg Oncol (2011) 0.99
Everolimus plus exemestane as first-line therapy in HR⁺, HER2⁻ advanced breast cancer in BOLERO-2. Breast Cancer Res Treat (2013) 0.99
Tumor inhibitory effect of gefitinib (ZD1839, Iressa) and taxane combination therapy in EGFR-overexpressing breast cancer cell lines (MCF7/ADR, MDA-MB-231). Int J Cancer (2007) 0.99
Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acid. Cancer (2012) 0.99
Effects of lifestyle and single nucleotide polymorphisms on breast cancer risk: a case-control study in Japanese women. BMC Cancer (2013) 0.98
Detection of occult cancer cells in peripheral blood and bone marrow by quantitative RT-PCR assay for cytokeratin-7 in breast cancer patients. Int J Oncol (2005) 0.98
Y-box binding protein-1 (YB-1) promotes cell cycle progression through CDC6-dependent pathway in human cancer cells. Eur J Cancer (2010) 0.98
Generation of measles virus with a segmented RNA genome. J Virol (2006) 0.97
F-box protein FBXW7 inhibits cancer metastasis in a non-cell-autonomous manner. J Clin Invest (2015) 0.97
Prognostic value of c-erbB2 expression in breast cancer. J Surg Oncol (2002) 0.97
Concurrent overexpression of Ets-1 and c-Met correlates with a phenotype of high cellular motility in human esophageal cancer. Int J Cancer (2002) 0.97
Vimentin as a poor prognostic factor for triple-negative breast cancer. J Cancer Res Clin Oncol (2013) 0.96
Measles viruses possessing the polymerase protein genes of the Edmonston vaccine strain exhibit attenuated gene expression and growth in cultured cells and SLAM knock-in mice. J Virol (2008) 0.96
Identification of recurrence-related microRNAs in the bone marrow of breast cancer patients. Int J Oncol (2011) 0.96
Relationship specialization amongst sources and receivers of social support and its correlations with loneliness and subjective well-being: a cross sectional study of Nepalese older adults. Arch Gerontol Geriatr (2006) 0.96
Randomized phase II study of weekly paclitaxel with and without carboplatin followed by cyclophosphamide/epirubicin/5-fluorouracil as neoadjuvant chemotherapy for stage II/IIIA breast cancer without HER2 overexpression. Breast Cancer Res Treat (2014) 0.94
Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis. Breast Cancer Res Treat (2014) 0.94
Diagnostic performance in differentiation of breast lesion on digital mammograms: comparison among hard-copy film, 3-megapixel LCD monitor, and 5-megapixel LCD monitor. Clin Imaging (2011) 0.93
Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study). Support Care Cancer (2008) 0.93
Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients. Cancer Chemother Pharmacol (2010) 0.93
Correlations between apparent diffusion coefficient values and prognostic factors of breast cancer. Magn Reson Med Sci (2013) 0.93
First-line bevacizumab in combination with weekly paclitaxel for metastatic breast cancer: efficacy and safety results from a large, open-label, single-arm Japanese study. Breast Cancer Res Treat (2011) 0.93
Physicians' attitudes about artificial feeding in older patients with severe cognitive impairment in Japan: a qualitative study. BMC Geriatr (2007) 0.92
Ki67 index changes, pathological response and clinical benefits in primary breast cancer patients treated with 24 weeks of aromatase inhibition. Cancer Sci (2011) 0.92
Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphamide chemotherapy. Support Care Cancer (2015) 0.92
Identification of molecular markers for metastasis-related genes in primary breast cancer cells. Clin Exp Metastasis (2005) 0.92
Diagnosis of complete response to neoadjuvant chemotherapy using diagnostic imaging in primary breast cancer patients. Breast J (2005) 0.92
Study of low-dose capecitabine monotherapy for metastatic breast cancer. Chemotherapy (2010) 0.92
Correlated expression of CD47 and SIRPA in bone marrow and in peripheral blood predicts recurrence in breast cancer patients. Clin Cancer Res (2010) 0.91
Detection of non-palpable breast cancer in asymptomatic women by using unenhanced diffusion-weighted and T2-weighted MR imaging: comparison with mammography and dynamic contrast-enhanced MR imaging. Eur Radiol (2010) 0.91
Clinicopathological features of young patients (<35 years of age) with breast cancer in a Japanese Breast Cancer Society supported study. Breast Cancer (2013) 0.91
Significant survival improvement of patients with recurrent breast cancer in the periods 2001-2008 vs. 1992-2000. BMC Cancer (2011) 0.90
Male breast cancer originating in an accessory mammary gland in the axilla: a case report. Case Rep Med (2012) 0.90
Preoperative chemoradiotherapy for esophageal cancer: factors associated with clinical response and postoperative complications. Anticancer Res (2009) 0.90
Primary small cell carcinoma of the breast. Breast Cancer (2008) 0.90
Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers. Breast Cancer Res Treat (2013) 0.90
MR imaging features of pure mucinous carcinoma of the breast. Eur J Radiol (2006) 0.89
Late phase II clinical study of vinorelbine monotherapy in advanced or recurrent breast cancer previously treated with anthracyclines and taxanes. Jpn J Clin Oncol (2005) 0.89
Predictive value of CD24 and CD44 for neoadjuvant chemotherapy response and prognosis in primary breast cancer patients. J Med Dent Sci (2010) 0.89
Measles virus receptors and tropism. Jpn J Infect Dis (2006) 0.89
Clinical usefulness of high-dose toremifene in patients relapsed on treatment with an aromatase inhibitor. Breast Cancer (2009) 0.89
Expression of ALDH1 in axillary lymph node metastases is a prognostic factor of poor clinical outcome in breast cancer patients with 1-3 lymph node metastases. Breast Cancer (2012) 0.89
Cystatin-like metastasis-associated protein mRNA expression in human colorectal cancer is associated with both liver metastasis and patient survival. Clin Cancer Res (2002) 0.89